يعرض 1 - 20 نتائج من 72 نتيجة بحث عن '"Ho, P-R"', وقت الاستعلام: 0.57s تنقيح النتائج
  1. 1
    Academic Journal
  2. 2
    Academic Journal
  3. 3
    Academic Journal
  4. 4
    Academic Journal
  5. 5
    Academic Journal
  6. 6
    Academic Journal
  7. 7
    Academic Journal
  8. 8
    Academic Journal
  9. 9
    Academic Journal
  10. 10
  11. 11
    Academic Journal
  12. 12
    Academic Journal
  13. 13
    Academic Journal

    Relation: pii: 10.1177_17562864211042458; Butzkueven, H., Kappos, L., Spelman, T., Trojano, M., Wiendl, H., Su, R., Liao, S., Hyde, R., Licata, S., Ho, P. -R. & Campbell, N. (2021). No evidence for loss of natalizumab effectiveness with every-6-week dosing: a propensity score-matched comparison with every-4-week dosing in patients enrolled in the Tysabri Observational Program (TOP). THERAPEUTIC ADVANCES IN NEUROLOGICAL DISORDERS, 14, https://doi.org/10.1177/17562864211042458.; http://hdl.handle.net/11343/296844

  14. 14
    Academic Journal

    Relation: pii: bmjopen-2020-038861; Butzkueven, H., Licata, S., Jeffery, D., Arnold, D. L., Filippi, M., Geurts, J. J., Santra, S., Campbell, N., Ho, P. -R. & REVEAL Investigators, (2020). Natalizumab versus fingolimod for patients with active relapsing-remitting multiple sclerosis: results from REVEAL, a prospective, randomised head-to-head study. BMJ Open, 10 (10), pp.e038861-. https://doi.org/10.1136/bmjopen-2020-038861.; http://hdl.handle.net/11343/251772

  15. 15
  16. 16
    Periodical

    المصدر: AIP Conference Proceedings Online; October 2023, Vol. 2837 Issue: 1 p090001-90007, 7p

  17. 17
    Periodical
  18. 18
    Academic Journal

    المصدر: Industrial & Engineering Chemistry Research; 2/8/2023, Vol. 62 Issue 5, p2240-2254, 15p

  19. 19
    Periodical

    المصدر: Orthopedics Today; May2024, Vol. 44 Issue 5, p1-8, 4p

  20. 20
    Periodical